Buprenorphine Hydrochloride Sublingual
Product Images NDC 67046-997

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride Sublingual (NDC 67046-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets Ciii 2 mg Bottle Label (D2288167 C532 4fb4 Abe3 F362492b9e5a 03)

Label for Buprenorphine Hydrochloride Sublingual 2 mg tablets, package of 30, labeled as a controlled substance for prescription use only. The label indicates packaging by Contract Pharmacy Services-PA, with storage instructions at 20-25°C (68-77°F). Each tablet contains 2.16 mg buprenorphine HCl, equivalent to 2 mg base. Includes lot, expiration date, and barcodes.*

FDA Label Image

Buprenorphine Hydrochloride Sublingual Tablets Ciii 8 mg Bottle Label (D2288167 C532 4fb4 Abe3 F362492b9e5a 04)

Label for Buprenorphine Hydrochloride Sublingual 8 mg tablets, 30 count, packaged by Contract Pharmacy Services-PA. The label includes barcodes, controlled substance designation, lot number TEST, expiration date 09/12/18, and storage instructions at 20-25°C (68-77°F). Each tablet contains 8.64 mg buprenorphine HCl equivalent to 8 mg base. CPS NDC: 67046-997-30.*

FDA Label Image

Buprenorphine Hydrochloride Structural Formula (Image 01)

Chemical structure of Buprenorphine Hydrochloride, showing its molecular framework including rings, hydroxyl, methoxy groups, and the hydrochloride component.*

FDA Label Image

Medication Guide Tablet Placement (Image 02)

An instructional illustration showing the placement of a buprenorphine hydrochloride sublingual tablet under the tongue inside an open mouth. The image focuses on demonstrating the proper sublingual administration method for the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.